LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Neratinib | 1.11 | uM | LJP5 | 72 | hr | 1694 | 3257 | 11103 | 0.2935 | 0.2712 |
MCF 10A | Neratinib | 3.33 | uM | LJP5 | 72 | hr | 1694 | 2674 | 11103 | 0.2409 | 0.1829 |
MCF 10A | Neratinib | 10 | uM | LJP5 | 72 | hr | 1694 | 2463 | 11103 | 0.2218 | 0.1474 |
MCF 10A | JW-7-24-1 | 0.04 | uM | LJP6 | 72 | hr | 1694 | 11170 | 11217 | 0.9960 | 0.9969 |
MCF 10A | JW-7-24-1 | 0.12 | uM | LJP6 | 72 | hr | 1694 | 11636 | 11217 | 1.0373 | 1.0270 |
MCF 10A | JW-7-24-1 | 0.37 | uM | LJP6 | 72 | hr | 1694 | 11550 | 11217 | 1.0298 | 1.0217 |
MCF 10A | JW-7-24-1 | 1.11 | uM | LJP6 | 72 | hr | 1694 | 11652 | 11217 | 1.0389 | 1.0281 |
MCF 10A | JW-7-24-1 | 3.33 | uM | LJP6 | 72 | hr | 1694 | 11504 | 11217 | 1.0258 | 1.0187 |
MCF 10A | JW-7-24-1 | 10 | uM | LJP6 | 72 | hr | 1694 | 3936 | 11217 | 0.3510 | 0.3623 |
MCF 10A | Dasatinib | 0.04 | uM | LJP5 | 72 | hr | 1694 | 8979 | 11103 | 0.8088 | 0.8485 |
MCF 10A | Dasatinib | 0.04 | uM | LJP6 | 72 | hr | 1694 | 6203 | 11217 | 0.5530 | 0.6087 |
MCF 10A | Dasatinib | 0.12 | uM | LJP5 | 72 | hr | 1694 | 6014 | 11103 | 0.5418 | 0.5951 |
MCF 10A | Dasatinib | 0.12 | uM | LJP6 | 72 | hr | 1694 | 3709 | 11217 | 0.3307 | 0.3328 |
MCF 10A | Dasatinib | 0.37 | uM | LJP5 | 72 | hr | 1694 | 3080 | 11103 | 0.2774 | 0.2464 |
MCF 10A | Dasatinib | 0.37 | uM | LJP6 | 72 | hr | 1694 | 2661 | 11217 | 0.2373 | 0.1800 |
MCF 10A | Dasatinib | 1.11 | uM | LJP5 | 72 | hr | 1694 | 2422 | 11103 | 0.2181 | 0.1403 |
MCF 10A | Dasatinib | 1.11 | uM | LJP6 | 72 | hr | 1694 | 2061 | 11217 | 0.1837 | 0.0739 |
MCF 10A | Dasatinib | 3.33 | uM | LJP5 | 72 | hr | 1694 | 1852 | 11103 | 0.1669 | 0.0326 |
MCF 10A | Dasatinib | 3.33 | uM | LJP6 | 72 | hr | 1694 | 1327 | 11217 | 0.1183 | -0.0876 |
MCF 10A | Dasatinib | 10 | uM | LJP5 | 72 | hr | 1694 | 1251 | 11103 | 0.1127 | -0.1061 |
MCF 10A | Dasatinib | 10 | uM | LJP6 | 72 | hr | 1694 | 871 | 11217 | 0.0776 | -0.2227 |
MCF 10A | Tozasertib | 0.04 | uM | LJP5 | 72 | hr | 1694 | 6349 | 11103 | 0.5718 | 0.6273 |
MCF 10A | Tozasertib | 0.12 | uM | LJP5 | 72 | hr | 1694 | 2001 | 11103 | 0.1802 | 0.0632 |
MCF 10A | Tozasertib | 0.37 | uM | LJP5 | 72 | hr | 1694 | 2067 | 11103 | 0.1862 | 0.0760 |
MCF 10A | Tozasertib | 1.11 | uM | LJP5 | 72 | hr | 1694 | 1973 | 11103 | 0.1777 | 0.0578 |